search
long-read genome sequencing
Trends
- 1Sweden Adds PacBio Long-Read Sequencing for Rare Disease Diagnosis▼Genome Medicine Sweden Introduces PacBio Long-Read Sequencing for Rare Disease Dx
Genome Medicine Sweden is introducing PacBio long-read sequencing into its diagnostic workup for rare diseases. The technology can detect complex genetic variants that short-read sequencing often misses, potentially improving diagnosis rates for patients with previously unexplained conditions. The move marks one of the broader adoptions of long-read sequencing in a national healthcare genomics program.
- 2GeneDx adds long-read genome sequencing to boost rare disease diagnosis●GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
GeneDx announced it is expanding into long-read genome sequencing, a technology it says will strengthen its rare disease diagnostics business and improve detection of complex genetic variants that short-read methods can miss. The company positions the move as extending its leadership in genome-based diagnostics for patients with unexplained rare conditions, a market where diagnostic yield has long been a key differentiator.
- 3Verily Health to Integrate PacBio HiFi Sequencing Into Data Platform●Verily Health to Integrate PacBio HiFi Sequencing With Data Platform
Verily Health announced plans to integrate PacBio's HiFi sequencing technology with its data platform, combining highly accurate long-read genomic sequencing with the company's health data infrastructure. The move is aimed at supporting more detailed genomic analysis and research, and it links two prominent players in the genomics and health technology space.